Astragaloside IV supplementation attenuates cognitive impairment by inhibiting neuroinflammation and oxidative stress in type 2 diabetic mice

Although diabetic cognitive impairment is one of the most common complications of type 2 diabetes mellitus (T2DM), optimized therapeutic strategies are not available yet. Astragalosides IV (AS-IV) is a traditional Chinese medicine possessing diverse pharmacological properties including anti-inflamma...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yaxuan, Yuan, Yuan, Zhang, Jiawei, Zhao, Yao, Zhang, Yueqi, Fu, Jianliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Aging Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557080/
https://www.ncbi.nlm.nih.gov/pubmed/36247985
http://dx.doi.org/10.3389/fnagi.2022.1004557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557080/
https://www.ncbi.nlm.nih.gov/pubmed/36247985
http://dx.doi.org/10.3389/fnagi.2022.1004557

Ejemplares similares